(19)

(11)

EP 4 125 647 A1

(12)

(43) Date of publication: 08.02.2023 Bulletin 2023/06 (21) Application number: 21776385.3 (22) Date of filing: 24.03.2021

(51) International Patent Classification (IPC):  A61B 17/34(1968.09) A61M 25/00(1968.09) A61B 17/00(1968.09) (52) Cooperative Patent Classification (CPC): A61B 17/3478; A61B 2017/00247; A61B 2017/3488; A61B 2017/3486; A61B 2017/22038; A61B 2017/22054; A61B 2017/22071; A61B 2017/003; A61B 2017/00318; A61B 2017/00309; A61B 2090/508; A61B 2017/00314; A61B 2017/00336; A61B 2017/22061; A61B 2017/3447; A61B 2090/0801 (86) International application number: PCT/US2021/023930 (87) International publication number: WO 2021/195243 (30.09.2021 Gazette 2021/39)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 25.03.2020 US 202062994751 P (71) Applicant: Protaryx Medical Inc. Baltimore, MD 21201 (US)	(72) Inventors: BAUER, Ryan Plymouth, Minnesota 12700 (US) HLAVKA, Edwin Minneapolis, Minnesota 55405 (US) (74) Representative: Cooley (UK) LLP  22 Bishopsgate London EC2N 4BQ London EC2N 4BQ (GB)